Clinical Trial Update: Clinical Observation on the Safety and Efficacy of Cardonilmab in the Treatment of Second-line and Above Advanced Melanoma and Advanced Renal Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update on Cardonilmab for second-line or higher advanced melanoma and advanced renal cancer, focusing on safety and preliminary efficac…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma
• Renal Cell Carcinoma

Drugs mentioned

• Cardonilmab (Cardonilmab)

Snippet

Sponsor: YongZhang | Conditions: Participants Who Had Received Second-line or Higher Advanced Melanoma and Advanced Renal Cancer | Phase 2 | Status: NOT_YET_RECRUITING